EXCESSIVE DAYTIME SLEEPINESS
Clinical trials for EXCESSIVE DAYTIME SLEEPINESS explained in plain language.
Never miss a new study
Get alerted when new EXCESSIVE DAYTIME SLEEPINESS trials appear
Sign up with your email to follow new studies for EXCESSIVE DAYTIME SLEEPINESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for chronic sleepiness: drug shows Long-Term promise
Disease control CompletedThis study looked at the long-term safety and effectiveness of the drug pitolisant for adults with idiopathic hypersomnia, a condition causing excessive daytime sleepiness. All 119 participants had completed a prior study of the same drug. Researchers measured sleepiness and othe…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug shows promise for narcolepsy symptom control
Symptom relief CompletedThis study tested the long-term safety and effectiveness of AXS-12 in 68 people with narcolepsy who experience sudden muscle weakness (cataplexy) and severe daytime sleepiness. Participants had already completed an earlier study of the same drug. The goal was to see if AXS-12 can…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 07:57 UTC
-
Sleep apnea drug shows promise for brain fog
Symptom relief CompletedThis study tested whether solriamfetol, a medication for excessive daytime sleepiness, can also improve cognitive function (like memory and attention) in adults with obstructive sleep apnea who still feel sleepy and have trouble thinking clearly. 59 participants took either the d…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE4 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC